(Q33201684)

English

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

cerebral blood flow

0 references

cerebral infarction

1 reference

based on heuristic

inferred from title

transient cerebral isolation

1 reference

based on heuristic

inferred from title

Michael Forsting

5

object named as

Michael Forsting

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Tobias Engelhorn

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sophia Goerike

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Arnd Doerfler

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Christine Okorn

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Gerd Heusch

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Rainer Schulz

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Journal of Cerebral Blood Flow & Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

467-474

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

https://scigraph.springernature.com/pub.10.1097/00004647-200404000-00012

0 references

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Decompressive craniectomy, reperfusion, or a combination for early treatment of acute "malignant" cerebral hemispheric stroke in rats? Potential mechanisms studied by MRI.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Captopril improves neurologic outcome from incomplete cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200404000-00012

21 January 2018

Identifiers

10.1097/00004647-200404000-00012

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dimensions Publication ID

0 references

release_eeiueeqycjdm5pouismcr3sf5i

1 reference

https://api.fatcat.wiki/v0/release/eeiueeqycjdm5pouismcr3sf5i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33201684&oldid=1843165862"